← Open Payments lookup

MARY COLLIGNON: Open Payments

NPI 1194728477 · SHAFTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$974 in 39 payments from 16 companies in 2025. Trend: 2023 $453 · 2024 $1,287 · 2025 $974

Food & beverage: $974
CompanyPaymentsAmount
Amgen Inc.10$201
Corcept Therapeutics2$141
Lilly USA, LLC4$132
Phathom Pharmaceuticals, Inc.2$82
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$76
Novo Nordisk Inc3$69
AstraZeneca Pharmaceuticals LP3$47
Kowa Pharmaceuticals America, Inc.2$33
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
Phadia US Inc.1$25

Products named: Korlym, Repatha, ZEPBOUND, VOQUEZNA, CAPLYTA, OTEZLA, Ozempic, MOUNJARO.

Industry payments across CA — which companies pay providers there.